D.E. Shaw & Co’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-666,018
Closed -$6.81M 5014
2022
Q4
$6.81M Buy
666,018
+101
+0% +$1.02K 0.01% 1806
2022
Q3
$6.65M Buy
665,917
+33,862
+5% +$336K 0.01% 1763
2022
Q2
$6.3M Buy
632,055
+930
+0.1% +$9.18K 0.01% 1854
2022
Q1
$6.19M Buy
631,125
+201,785
+47% +$1.98M 0.01% 2075
2021
Q4
$4.21M Buy
+429,340
New +$4.19M ﹤0.01% 2576

Other funds holding PEPL

D.E. Shaw & Co's PEPL Position: Q1 2023 in Review

D.E. Shaw & Co sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 666,018 shares — an estimated $6.81M sold.

D.E. Shaw & Co first reported a position in PEPL in Q4 2021 and held it in 5 quarters. The position peaked at $6.81M in Q4 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • D.E. Shaw & Co reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 666,018 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $6.81M.
  • D.E. Shaw & Co first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
  • D.E. Shaw & Co's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $6.81M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.